from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0506/mmpS2

LFCtreatmentdescriptionclass of inhibitor

0.295

Amikacinug/mL Amikacintranslation

0.156

Cap5-10ug/mL Capreomycintranslation

0.462

Rox10-50 ug/mL Roxithromycintranslation

-0.618

SM2-5 ug/mL Streptomycintranslation

-0.364

Tet5-10 ug/mL Tetracyclinetranslation

-0.418

Rif0.2-5ug/mL Rifampicintranscription

-0.561

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.504

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.444

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.261

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.494

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.227

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.278

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.165

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.141

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.125

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.001

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.056

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.273

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.502

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.578

KCN5-20 ug/mL Potassium cyaniderespiration

-0.949

NaN30.2-2 mM Sodium aziderespiration

-0.103

Nigericin50 uM Nigericinrespiration

0.425

TRC10-150 ug/mL Triclosanrespiration

-0.607

TRZ10-25 ug/mL Thioridazinerespiration

-1.245

Valinomycin0.5-10 uM Valinomycinrespiration

-0.223

ZnSO42 mM ZnSO4respiration

-1.205

menadione6-10 ug/mL Menadionerespiration

0.228

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.341

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.260

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.196

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.747

NRP_1Non-replicating persistence stage 1dosRassociated

0.109

Amp0.2mg/mL AmpicillincellWall

0.356

Cephalexin20-100 ug/mL CephalexincellWall

0.239

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.817

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.266

EMB10-20 ug/mL EthambutolcellWall

-0.116

Eta12-40 ug/mL EthionamidecellWall

-0.002

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.282

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.364

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.178

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.125

BZA0.12 mg/mL BenzamidearomaticAmides

1.480

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.492

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.353

H2O24 mM hydrogen peroxideDNAdamaging

0.023

Levo10 ug/mL LevofloxacinDNAdamaging

0.568

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.987

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.202

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.628

UVUV-irradiationDNAdamaging

-1.149

ARP41-4 ug/mL Antitubercular compound ARP4?

0.251

Antimycin12.5-50 ug/mL Antimycin A?

0.088

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.323

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.193

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.104

PA8240.2-2 ug/mL PA-824?

-1.113

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.288

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.049

Verapamil50 uM Verapamil?

0.086

mercaptoethanol2 mM 2-Mercaptoethanol?

0.143

methoxatin10-20 ug/mL Methoxatin?